Transitional cell carcinoma
Not yet recruitingNeoadjuvant Study of Avelumab with Gemcitabine and Cisplatin versus Chemotherapy Alone in Patients with High‑Grade Localized Upper Tract Urothelial Carcinoma
Neoadjuvant Study of Avelumab with Gemcitabine and Cisplatin versus Chemotherapy Alone in Patients with High‑Grade Localized Upper Tract Urothelial Carcinoma
- Disease:Transitional cell carcinoma
- Substances:AvelumabCisplatin+1
France- Participants:18–64 years · 65+ years
- Substances:Avelumab
- Sponsor:Centre Hospitalier Universitaire De Nimes




